Searched for
DIVIS LABORATORIES RESULTS
For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some not- Divi's Laboratories Q4 Results: Cons PAT grows 13% YoY to Rs 751 crore, revenue up 10%; Rs 30 per share dividend announced
- Mankind, other pharma stocks rally up to 7%; Nifty Pharma scales fresh peak. What lies ahead?
- Divi’s Laboratories Q2 Results: Cons profit jumps 35% YoY to Rs 689 crore, revenue up 16%Divi's Laboratories reported a robust financial performance for the second quarter of FY26, with consolidated net profit soaring by 35% yea...07 Nov, 2025, 12.41 PM IST
- Divi’s Laboratories Q1 Results: Cons net profit rises 27% YoY to Rs 545 crore, revenue up 14%Divi’s Laboratories Q1 Results: The Hyderabad-based pharma giant posted a consolidated revenue of ₹2,410 crore from operations in the first...06 Aug, 2025, 01.33 PM IST
- Divi’s Lab shares up 3% after Q4 PAT surges 26% YoY. Should you invest?Divi's Laboratories reported a strong Q4FY25, with a 26% YoY increase in net profit to Rs 667 crore and a 12.26% rise in revenue to Rs 2,53...19 May, 2025, 09.22 AM IST
- Divi’s Laboratories Q4 results: PAT surges 26% YoY, revenue up 12%Divi's Laboratories announced a robust financial performance for the March quarter of FY25, with a 25.6% YoY surge in standalone net profit...17 May, 2025, 02.29 PM IST
- Divi's Labs Q3 Results: Cons PAT jumps 64% YoY to Rs 589 crore, revenue up 25%Divi's Labs Q3 Results: Divi's Laboratories reported a significant 64% year-on-year increase in its December quarter net profit, reaching R...03 Feb, 2025, 01.39 PM IST
- Divi’s Laboratories Q2 Results: Company posts 47% jump in net profit in Q2FY25Divi's Laboratories witnessed a 46.6% surge in profit, reaching Rs. 510 crores in Q2FY25, fueled by robust growth in their custom synthesis...10 Nov, 2024, 09.14 AM IST
- Divi's Laboratories Q2 Results: PAT jumps 46% YoY to Rs 510 crore on forex gainDivi's Laboratories Q2 Results: The company reported a 22.5% year-on-year revenue increase in Q2, reaching Rs 2,338 crore, up from Rs 1,909...09 Nov, 2024, 02.47 PM IST
- Divi’s Laboratories shares rally 5% post Q4 results. Should you buy, sell or hold?Divi’s Laboratories saw a 5% surge in its shares on the BSE during Monday's trading session, reaching a new 52-week high of Rs 4,335. This ...27 May, 2024, 11.16 AM IST
- Divi's Laboratories Q4 Results: Cons PAT soars 68% YoY to Rs 538 crore; dividend declared at Rs 30 per shareDivi's Laboratories Q4 Results: Net profit stood at Rs 321 crore in the corresponding quarter of the last financial year. The consolidated ...25 May, 2024, 01.47 PM IST
- Q3 Results Today: Divi’s Lab, ONGC, MCX among 170 companies to announce earningsAmong other important results will be those by Aurobindo Pharma, Chemcon Speciality Chemicals, Sai Silks (Kalamandir), Mawana Sugars, MM Fo...10 Feb, 2024, 10.05 AM IST
- Divi's Lab shares jump over 9% as exports rise in MarchThe consensus recommendation from 23 analysts for Divi's Lab is Sell. Out of these analysts, only six have strong buy and buy ratings, whil...12 Apr, 2023, 02.44 PM IST
- Divi’s Labs Q4 Results: Profit surges 78% YoY to Rs 895 crore, beats estimatesThe Board of Directors of the company has recommended a dividend of Rs 30 per share for the financial year 2021-22, subject to approval of ...24 May, 2022, 10.23 AM IST
- Divi's Labs shares fall 9% post Sept quarter numbers; here's whyWe envisage near term pressures growin for Divi's Labs, with rising raw material prices, logistical issues and declining generics business,...08 Nov, 2021, 10.56 AM IST
- Divi’s Labs hits all-time high after robust Q2 resultsA recent entrant to the Nifty pack, Divi’s Labs is up 82 per cent year-to-date, and has almost doubled over the last one year.09 Nov, 2020, 01.14 PM IST
- Divi's Laboratories shares zoom over 18% after Q1 resultsShares of Divi's Laboratories on Monday rallied over 18 per cent after the company reported 80.61 per cent rise in consolidated net profit ...10 Aug, 2020, 12.14 PM IST
- Divi's Laboratories shares down nearly 3 per cent post earningsShares of drug firm Divi's Laboratories fell by nearly 3% after the company's first quarter results failed to meet market expectations.12 Aug, 2014, 05.56 PM IST
- Divi's Lab shares down over 4% post earningsDivi's Laboratories had yesterday reported a standalone net profit of Rs 167.93 crore for the first quarter ended June 30.12 Aug, 2014, 12.38 PM IST
Load More
